For this purpose, different functionalized nanomaterials have been designed for targeted delivery of a small-molecule HSP inhibitor or a glucose-deprivation nanoagent to reduce the heat resistance of cancer cells and enhance the therapeutic efficacy of mild-temperature PTT. This evidence concerns the gene HSP90B2P and cancer.